ASP Isotopes (ASPI, Financial) has named Dr. Ryno Pretorius, Ph.D., as the Chief Executive Officer of its subsidiary, Quantum Leap Energy. This division focuses on the innovation and commercialization of cutting-edge nuclear fuels, including High Assay Low-Enriched Uranium and Lithium-6. Dr. Pretorius brings a wealth of experience to this role, having served as a consultant for both ASP Isotopes and Quantum Leap Energy.
While Dr. Pretorius takes on his new responsibilities, Paul Mann remains in his positions as the chairman and CEO of ASPI, as well as the chairman of Quantum Leap Energy. Previously, Dr. Pretorius held positions as technical director and CEO at Free Radical Process Design, where he contributed his expertise for a decade.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 2 analysts, the average target price for ASP Isotopes Inc (ASPI, Financial) is $7.75 with a high estimate of $11.00 and a low estimate of $4.50. The average target implies an downside of 11.02% from the current price of $8.71. More detailed estimate data can be found on the ASP Isotopes Inc (ASPI) Forecast page.
Based on the consensus recommendation from 2 brokerage firms, ASP Isotopes Inc's (ASPI, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
